MAKING A NEW WAVE WITH
PREDICTIVE BIOMARKERS
We Hope to Make a World Free From Cancer by Developing
First-in-Class Anticancer Drugs Based on Predictive Biomarkers
We Hope to Make a World Free From Cancer by Developing
First-in-Class Anticancer Drugs Based on Predictive Biomarkers
We develop first-in-class anticancer drugs based on predictive biomarkers for unmet medical needs.
By utilizing clinical information from one of the largest hospital in South Korea, we hope to make a world free from cancer.
Our dedicated researchers are making ceaseless efforts to develop new anticancer drugs.
We will continue to strive for the healthy life of mankind.
Our researchers are developing predictive biomarkers that could identify patient's drug response to a certain therapy.
As a result, we can shorten the lead time, reduce the development cost and
increase the success rate in first-in-class anticancer drugs.
Wellmarker Bio, a company committed to discovering and developing first-in-class anti-cancer drugs with predictive biomarkers, presented precl...
2021-04-13Wellmarker Bio, a company specialized in predictive biomarker-based novel anti-cancer drug development was founded in 2016 with professor Dong...
2021-04-05Wellmarker Bio’s WM-S1-030 program has been registered on the ClinicalTrials.gov website on March 16, 2021. This study will evaluate t...
2021-03-19